// App-Quantinova.ai

P058 : An Exploratory Analysis of the Efficacy of Cladribine Tablets in Patients with RMS Stratified According to Age Above and below 45 Years in CLARITY

Researchers

Presenter

  • Kottil W Rammohan

Principal Investigators

  • Gavin Giovannoni

  • Stuart D Cook

  • Per Soelberg-Sorensen

  • Patrick Vermersch

  • Birgit Keller

  • Elisabetta Verdun di Cantogno

Medical Centers

  • Queen Mary University of London and Blizard Institute Barts and The London School of Medicine and Dentistry London United Kingdom

  • University of Miami, Miami, FL

  • Rutgers, The State University of New Jersey, New Jersey Medical School Newark NJ United States

  • 2Danish Multiple Sclerosis Registry, Copenhagen University Hospital København Ø Denmark

  • University Hospital of Lille, Lille, France

  • Merck KGaA, Darmstadt, Germany

Locations

  • United Kingdom

  • United States

  • Denmark

  • France

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Cladribine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A